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ABSTRACT 
Purpose: To determine differences in overall tumor responses measured by volumetric 
assessment and bioluminescence imaging (BLI) following exposure to uniform and non-
uniform radiation fields in an ectopic prostate tumour model. 
Materials and Methods: Bioluminescent human prostate tumor xenografts were 
established by subcutaneous implantation into male mice. Tumors were irradiated with 
uniform or non-uniform field configurations using conventional in vivo irradiation 
procedures performed using a 225 kVp generator with custom lead shielding. Tumor 
responses were measured using Vernier calipers and by BLI using an in vivo imaging 
system. Survival was defined as the time to quadroupling of pre-treatment tumor volume. 
Results: The correlation between BLI and tumor volume measurements was found to be 
different for un-irradiated (R = 0.61), uniformly irradiated (R = 0.34) and partially 
irradiated (R = 0.30) tumors. Uniformly irradiated tumors resulted in an average tumour 
growth delay of 60 days with median survival of 75 days, compared to partially irradiated 
tumors which showed an average growth delay of 24 days and median survival of 38 
days. 
Conclusions: 
Correlation between BLI and tumor volume measurements is lower for partially 
irradiated tumors than those exposed to uniform dose distributions. The response of 
partially irradiated tumors suggests non-uniformity in response beyond physical dose 
distribution within the target volume. Dosimetric uncertainty associated with 
conventional in vivo irradiation procedures prohibits their ability to accurately determine 
tumor response to non-uniform radiation fields and stresses the need for image guided 
small animal radiation research platforms. 
 
INTRODUCTION 
Small animal models are a fundamental tool for robust preclinical radiobiological 
investigations. Technological advances in the clinic, such as intensity modulated and 
image guided radiotherapy, have significantly outpaced those for the irradiation of 
laboratory animals under experimental conditions which has commonly been performed 
using fixed kilovoltage sources with custom lead shielding for beam targeting and 
sparing of normal tissues (Hillman et al, 2001; Know et al, 1992). 
This translational gap between experimental radiobiology and radiation oncology has 
been narrowed with the implementation of small animal image guided radiation research 
platforms (Verhaegen et al, 2011; Zhou et al, 2010; Wong et al, 2008) which combine 
high resolution cone beam computed tomography (CBCT) with orthovoltage radiation 
sources for accurate beam targeting allowing treatment of a defined target through a 
process analogous to that of contemporary clinical practice.  
The implementation of these platforms in the laboratory represents a significant 
advancement for in vivo radiobiological investigations enabling preclinical evaluation of 
novel regimes including hypofractionation, dose painting and drug radiation 
combinations. Furthermore, the development of small animal radiation research 
platforms with on board optical imaging will offer significant potential in radiation 
biology. 
A range of optical imaging and spectroscopy methods are widely used for radiobiological 
studies to determine cellular responses at the molecular level (Palmer et al, 2012). 
Bioluminescence imaging (BLI) is a highly sensitive, non-invasive in vivo imaging 
modality which measures photons generated by a luciferase reporter gene in the presence 
of the D-luciferin substrate injected prior to imaging (Inouye et al, 2010). BLI has been 
used to assess tumour burden in a range of preclinical models for localised and metastatic 
disease (O’Neill et al, 2010; Tuli et al, 2012; Al Nakouzi et al, 2012), however, its 
application in monitoring the efficacy of radiation exposure responses has been limited 
(Lee et al, 2010). 
In the present study, we aimed to compare tumour volume and BLI measurements to 
determine differences in overall tumor response following exposure to uniform and non-
uniform radiation fields in an ectopic prostate tumor model. This study also sought to 
provide in vivo support for the presence of out-of-field effects under non-uniform dose 
distributions. 
 
MATERIALS AND METHODS 
Cell culture  
PC-3-luc2 Bioware Ultra (Caliper Life Sciences, Runcorn, United Kingdom) is a stably 
transfected luciferase expressing variant of the human prostate cancer cell line PC-3 (Kaighn 
et al, 1979). Cells were grown in RPMI (Roswell Park Memorial Institute)-1640 medium 
with 10% fetal bovine serum, 1% penicillin / streptomycin (Gibco, Paisley, Scotland, UK) 
and maintained at 37°C in a humidified atmosphere of 95% air / 5% CO2. 
 
Animals, tumor implantation and maintenance 
6-8 week old male Fox Chase SCID (Severe combined immunodeficient) mice (Charles 
River Laboratories, Oxford, United Kingdom) were used as a xenograft model for PC-3-
luc2 cells. 1.5 x 106 cells in 100 μl of PBS (phosphate buffered saline) were implanted 
intra-dermally on to the flank of animals under inhalant anaesthesia. 5 animal were 
assigned to each experimental group (control, uniform irradiated, partially irradiated). 
Animals received food and water ad libitum. All experimental procedures were carried 
out in accordance with United Kingdom Home office approved protocols for in vivo 
experimentation.  
 
Irradiation procedure 
Tumors were grown for 4-8 weeks until reaching a pre-treatment volume of around 100 
mm3. Animals were assigned to three treatment groups, un-irradiated controls, 8 Gy 
irradiated animals delivered as a uniform field and 8 Gy irradiated animals delivered as 
non-uniform field in which 40-60% of the tumor volume was irradiated. Animals were 
restrained and custom lead shielding used to expose the complete or partial tumour 
volume to 225 kVp X-rays using a X-Rad 225 generator (Precision X-ray Inc, North 
Branford, Connecticut, USA).  A dose profile was generated using Gafchromic RTQA2 
film (Ashland, Covington, Kentucky, USA) placed under the lead shielding which show 
scattered dose fell to less than 10% of the target dose within 1 cm off axis as shown in 
figure 1. Animals were irradiated at a dose rate of 0.52 Gy min-1.  
 
Tumour volume measurements and BLI 
Tumor volume was determined three times a week from Vernier caliper measurements 
in three orthogonal dimensions. Tumour bearing mice were imaged weekly using an 
IVIS 100 (Caliper Life Sciences). Animals were intraperitoneally injected with D-
luciferin potassium salt (Caliper Life Sciences) at a concentration of 150 mg/kg and 
imaged 15 minutes after injection as determined from BLI kinetic studies in the same 
tumor model. The distribution of detected photons was overlaid onto a grayscale 
photographic image and a region of interest (ROI) manually selected. Signal intensity 
was quantified in photons/second/squared centimetre/steradian (p/s/cm2/Sr) for a ROI 
selected manually by applying the same threshold to each of the images using Living 
Image Software (Caliper Life Sciences). 
 
Statistical Analysis 
The correlation between tumour volume and BLI measurements was assessed using a 
linear regression of the form 𝑦𝑦 = 𝑚𝑚𝑚𝑚 + 𝑐𝑐, where x is the measured volume, y the BLI 
value, m the slope and c the y-intercept of the linear fit of the data. Significant 
correlation was evaluated using a two-tailed t test on m, with a significance threshold of 
0.05. All calculations were carried out using (GraphPad Prism, Version 5.01). 
 
RESULTS 
Correlation of tumor volume and BLI measurements 
Correlation of tumor volume and BLI measurements was determined for control, 
uniformly irradiated and partially irradiated tumours in a heterotopic prostate xenograft 
model. Photon emission from a manually selected region of interest showed maximum 
flux at 15 - 20 minutes after intraperitoneal injection of D-luciferin in animals pre-
treatment. Control and irradiated animals showed no significant difference in the kinetics 
of bioluminescence signal at the beginning of the experiment or when maximum 
tolerated tumour volume was reached at the end of the experiment (data not shown).  
Comparison of BLI and tumour volume for control, uniformly irradiated and partially 
irradiated tumours is shown in figure 2. Linear regression analysis showed significant 
correlation between tumor volume and BLI for control tumors (R = 0.6123). A less 
strong correlation between tumor volume and BLI was observed for uniformly irradiated 
tumours (R = 0.3417) and the least significant correlation shown for partially irradiated 
tumors (40 – 60% tumour volume; R = 0.3063). Significance testing of these correlation 
coefficients using a t-test indicated statistically significant correlation for control (p = 
0.01) and uniformly irradiated animals (p = 0.02) but no significant relationship for 
partially exposed tumors (p = 0.08).  
Tumor growth delay and overall survival 
Tumor volume measurements are shown for control, uniformly irradiated and partially 
irradiated animals in figure 3a. Comparing the data for control with uniformly irradiated 
tumours showed a significant growth delay of around 60 days which is reflected in the 
median survival of 14 and 75 days respectively as shown in figure 3b. Comparison of 
control with partially uniformly irradiated tumours showed a significant growth delay of 
around 24 days which is reflected in the median survival of 14 and 38 days respectively 
as shown in figure 3b. The mean fractional uncertainty in tumor volume measurements 
was found to be 0.12 for control animals compared to 0.26 for partially irradiated and 
0.24 for uniformly irradiated animals.  
 
DISCUSSION 
This study aimed to determine differences in the overall tumor response measured by 
volumetric assessment and BLI in un-irradiated and irradiated tumors exposed to 
uniform or non-uniform radiation fields. These experiments were conducted in the 
context of assessing BLI as a means to determine the effective spatial dependency of 
radiobiological effects occurring outside of the primary treatment field and to assess if 
this could be achieved using convention in vivo irradiation configurations.  
Tumors were implanted intra-dermally to minimise physical limitations of tissue depth, 
photon signal impedance and to improve tumour target definition. As the kinetics of 
luciferase is an important consideration in BLI studies, this was determined in animals 
pre- and post-irradiation. In agreement with previous reports (Kemper et al 2006; 
Burgos et al, 2003), maximum photon flux was observed 15 minutes post injection for 
both the control and irradiated animals. Time taken for acquisition of BLI was 
comparable to that of caliper measurements with both taking less than 1 minute.  
BLI is a powerful non-invasive tool for imaging of tumor burden in small animals 
(Klerk et al, 2007). Consistent with other reports (Klerk et al, 2007; Paroo et al, 2004), 
significant correlation between bioluminescence and tumour volume was observed for 
control tumours (R = 0.6123, p = 0.01) indicating utility of BLI for quantitative 
assessment of tumour burden. Correlation between these measurements decreased for 
uniformly irradiated tumours (R = 0.3417, p = 0.02) suggesting BLI is less accurate in 
predicting volume for irradiated ectopic tumours. We postulate that the observed 
differences in predictive power between control and irradiated tumours is a consequence 
of inaccuracies associated with caliper measurements as areas of necrosis and oedema 
may be measured in addition to viable tumour cells. In addition, similar discrepancy 
between BLI signal and tumor volume measured by magnetic resonance (MR) was 
reported by Jost et al, (2009) in an orthotopic brain tumor model showing poor 
correlation with very low BLI signal for very large tumor volumes. 
There may be significant biological heterogeneity in factors impacting on radiation 
response such as radiation induced cell death, damage to the tumour vascular damage 
and surrounding normal tissue and regions of hypoxia. These factors may also in part 
explain the poor correlation observed in partially irradiated tumours (R = 0.3063, p = 
0.08). Given the assumption of symmetrical tumors when using orthogonal 
measurements to calculate tumour volume, the relationship may be unsurprising. BLI 
may be a more accurate means of determining response to partial radiation fields where 
asymmetrical tumor volumes may result.  
Considering the differences in dose distributions between partially and uniformly 
irradiated tumors, this may also suggest a significant underlying biological component 
in response similar to the out-of-field effects observed in vitro in several studies from 
our laboratory (Trainor et al, 2012; Butterworth et al, 2011). Notably, the growth delay 
seen in partially-irradiated tumours (roughly 3 doubling times) is greater than would be 
expected even for complete killing of the irradiated portion of the tumour, this indicates 
a significant reduction in viability for out-of-field cells also. Further interpretation of the 
data from this study in the context of out-of-field effects is limited as the low spatial 
resolution of both the irradiation technique and BLI may be insufficient to detect 
significant variation in response occurring out-of-field.  
An improved approach may be the combination of BLI with accurate dose distributions 
offered through small animal image guided radiotherapy platforms. Furthermore, the 
development of tomographic optical imaging systems allowing the acquisition of BLI 
from multiple angles with reconstruction algorithms applying models of photon 
transport is likely to offer improved resolution in three dimensions. Although ectopic 
tumor models remain important experimental tools in biological sciences they fail to 
accurately recapitulate the tumour microenvironment in situ. To investigate tumour 
development and response to complex radiation fields delivered typically during 
advanced radiotherapy, the application of orthotopic tumour models may be more 
biologically relevant in recapitulating the tumor microenvironment. 
In summary, the data in this study show a clear correlation between tumor volume and 
BLI intensity. However, there may be significant inter-tumoral and inter-animal 
variations which may impact on absolute signal intensity particularly following 
irradiation. This study shows conventional in vivo radiation procedures using lead 
shielding are insufficient in accurately determining tumor responses to non-uniform 
radiation fields, stressing the need for the application of more accurate image guided 
small animal irradiation platforms in such investigations.  
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